NUCLEO C.M.P.®

  Núcleo C.M.P.® Forte



Núcleo C.M.P Forte

Activity

Núcleo CMP Forte provides the phosphate groups necessary for union of the monosaccharides with ceramins, to form the cerebrosides and phosphatidic acids constituting the sphingomyelin and glycerophospholipids, main components of the myelin sheath, thus achieving greater trophic properties for the maturation and axonal regeneration of the nervous tissue.


Composition                                                                    Per capsule          Per Lyophilized ampoule

Cytidine-5'-disodium monophosphate (CMP disodium salt) 5mg                         10mg

Uridine-5'-trisodium triphosphate (UTP trisodium salt)

Uridine-5'-disodium diphosphate (UDP disodium salt)

Uridine-5'-disodium monophosphate (UMP disodium salt)  3 mg                          6mg

(equivalent to 1.330 mg of Uridine and 2.660 mg of Uridine, respectively) 

Excipient..................................................................................q.s.                            q.s.

Per ampoule of solvent:

Sodium chloride

Aqueous vehicle, q.s. 2 ml.


Indications

Treatment of neuropathies of osteoarticular (sciatica, radiculitis, etc.), metabolic (diabetic, alcoholic polyneuritis, etc.), infectious (herpes zoster) origin, and a frigore. Neuralgia of the Facial, Trigeminal, Intercostal, Lumbago.


Dosage, form and duration of treatment

Núcleo CMP Forte injections is administered by intramuscular route.

Adults: 1 injection daily by intramuscular route.

Children: 1 injection every 2 days by intramuscular route.


Núcleo CMP Forte capsules is administered by oral route.

Adults: 1 or 2 capsules 2 times daily.

Children: 1 capsule 2 times daily. As prescribed by physician.


Precautions for use (Injections)

Introduce the whole contents of the ampoule of solvent into the lyophilized ampoule, stir till completely dissolving the contents of the latter. Inject by intramuscular route.


Contraindications

Are not known. Unless that there exists an allergy to any of the components.


Adverse reactions

Have not been described, but if any adverse reaction attributable to the taking of the medicament appears, consult your physician or pharmacist.


Interactions

Are not known.


Use during pregnancy

Its use during pregnancy is not contraindicated, however, it is recommended that the dosage patter is established by the physician.


Measures to be taken in case of overdosage

Given the scarce toxicity of the preparation, poisoning is not foreseen, even by accident.


Pharmaceutical form and contents

-Package containing 3 lyophilized ampoules and 3 ampoules of solvent.

- Package containing 30 capsules.


Conditions for the preservation and validity time

This medicament must not be used after the date of expiry stated on the package.


Medicaments must be kept out of reach and sight of children

Comments

Post a Comment

Popular posts from this blog

DEFLAT®

Image
Deflat ® Simethicone Properties: Deflat (Simethicone), is an antiflatulent drug that  reduces the surface tension of gas bubbles which may  be formed excessively in the gastrointestinal tract. Then,  small gas bubbles will coalesce forming larger bubbles  that can be easily expelled through belching or passing  flatus. Indications: • Deflat ® is indicated for the relief of painful symptoms  as: sensation of pressure, fullness in the epigastrium  and intestinal spasm due to excessive accumulation of  gases that may be formed in the digestive tract in the  following cases: - Air swallowing (aerophagia). - Functional dyspepsia. - Irritable bowel syndrome. - Peptic ulcer. - Postoperative gaseous distension. - Infant colic. - Gastro-cardiac symptom complex. • Deflat is used as a diagnostic aid to remove gases  from the gastrointestinal tract before gastroscopy,  x-ray examination and sonography of the spine and  abdominal organs....
Read more

®PROFILAR

Image
 Profilar ® Ketotifen Hydrogen Fumarate Description: PROFILAR ® (Ketotifen Hydrogen Fumarate) is a non-bronchodilator, potent anti-allergic and anti-asthmatic drug. It inhibits the ef fects of the inflammatory mediators, and thereby exerts its anti-allergic activity.  It also inhibits the release of allergic mediators such as  histamine and leukotrienes, suppresses the influx of eosinophils into inflammatory site and inhibits the development of airway hyper activity associated with activation of platelets by PAF (Platelet Activating Factor) or caused by neural activation following the use of  sympathomimetic drugs or the exposure to allergen, thereby exerts its anti-asthmatic activity. Properties: After oral administration the absorption of Ketotifen is nearly complete. Bioavailability is about 50% due to a first-pass effect of about  50% in the liver and its bioavailability is not influenced by food intake. Maximal plasma concentration reaches within 2-4 h...
Read more